CD8A and Ebola hemorrhagic fever: Despite success using this method for evaluating Ebolavirus specific T cells in long-term survivors of ebolavirus disease (EVD) [24,25], only 27% of long-term LF survivors had a measurable CD8+ T cell response (Fig 1A) using this method.